for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

White House says J&J COVID-19 shot shipments to be low until U.S. vaccine plant cleared by regulators

April 9 (Reuters) - Johnson & Johnson will ship relatively few COVID-19 shots around the United States until it receives regulatory clearance for a large vaccine plant in Baltimore that has struggled to meet quality control standards, a top White House Health official said on a Friday press conference.

J&J is working closely with regulators to resolve the issues holding up authorization, said Jeff Zients, the White House’s COVID-19 response coordinator. It expects to start shipping 8 million doses per week towards the end of April and remains on track to deliver around 100 million shots by the end of May, he added.

Reporting by Carl O’Donnell

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up